KJKee Ching G. Jeng

Kee Ching G. Jeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kee Ching G. Jeng has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Rolis Chien-Wei Hou

    Department of Medical Technology, Jen-Teh Junior College of Medical and Nursing Management, Miaoli, Taiwan

    4 shared publications
  • Rolis Chien‐Wei Hou

    Jen-Teh Junior College of Medical and Nursing Management, Miaoli, Taiwan

    3 shared publications
  • Hsueh‐Meei Huang

    Department of Education and Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan

    2 shared publications
  • Huan-Lian Chen

    Taichung Veterans General Hospital

    2 shared publications
  • Ben-Ching Liao

    Institute of Biomedical Science, National Chung Hsing University, Taichung, ROC

    1 shared publication
  • Chia-Chuan Wu

    Department of Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation

    by Peiyuan F Hsieh, Chien-Wei Hou, Pei-Wun Yao, Szu-Pei Wu, Yu-Fen Peng, Mei-Lin Shen, Ching-Huei Lin, Ya-Yun Chao, Ming-Hong Chang, Kee-Ching Jeng

    Kainic acid (KA)-induced status epilepticus (SE) was involved with release of free radicals. Sesamin is a well-known antioxidant from sesame seeds and it scavenges free radicals in several brain injury models. However the neuroprotective mechanism of sesamin to KA-induced seizure has not been studied.


  • Bromelain Inhibits Lipopolysaccharide-Induced Cytokine Production in Human THP-1 Monocytes via the Removal of CD14

    by Jing-Rong Huang, Chia-Chuan Wu, Rolis Chien-Wei Hou, Kee-Ching Jeng

    Bromelain has been reported to have anti-inflammatory and immunomodulatory effects. However, the anti-inflammatory mechanism of bromelain is unclear. Therefore, we investigated the effect of bromelain on cytokine production from lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells (PBMC) and monocytic leukemia THP-1 cells. The result showed that bromelain (50–100 μg/ml) significantly and reversibly reduced tumor necrosis factor (TNF)-α interleukin- (IL)-1β and IL-6 from LPS-induced PBMC and THP-1 cells. This effect was correlated with reduced LPS-induced TNF-α mRNA and NF-κB activity in THP-1 cells. In addition, bromelain dose-dependently inhibited LPS-induced prostaglandin E2, thromboxane B2 and COX-2 mRNA but not COX-1 mRNA. Importantly, bromelain degraded TNF-α and IL-1β molecules, reduced the expression of surface marker CD14 but not Toll-like receptor 4 from THP-1 cells. Taken together, the results suggest that the suppression of signaling pathways by bromelain's proteolytic activity may contribute to the anti-inflammatory activity of bromelain.


  • Enhancement of the release of inflammatory mediators by substance P in rat basophilic leukemia RBL-2H3 cells

    by Ben-Ching Liao, Rolis Chien-Wei Hou, Jen-Shu Wang, Kee-Ching G. Jeng

    Substance P (SP), a neurotransmitter, may play an important role in neurogenic inflammation. Ginseng has been used extensively in traditional medicine; however, few studies were focused on their anti-allergic effect. Therefore, the effect and mechanism of ginsenoside Rb1 on the SP enhancement of allergic mediators were explored. In this study, SP and dinitrophenyl-bovine serum albumin (DNP-BSA) were used to activate rat basophilic leukemia (RBL)-2H3 cells. The cultured supernatants were assayed for histamine, leukotriene C4(LTC4) and interleulin-4 (IL-4) production. The mitogen-activated protein kinases (MAPKs) signaling pathway was determined by Western blotting analysis. We found that IgE/DNP-BSA, SP, ginsenoside Rb1, or MAPK specific inhibitors had no effect on cell viability and cytotoxicity. SP (30 μM) alone, did not induce histamine and LTC4 release, but it enhanced allergen-induced histamine and LTC4 release. In␣addition, SP significantly induced and enhanced allergen-activated IL-4. Ginsenoside Rb1 dose-dependently inhibited these effects. SP enhanced the allergen-activated ERK pathway in RBL-2H3 cells, and Rb1 effectively inhibited the ERK pathway activation. Although MAPK specific inhibitors suppressed LTC4 and IL-4, only U0126 inhibited the SP enhanced histamine release. These results demonstrate that Rb1 dose-dependently inhibited SP enhanced allergen-induced mediator release and its mechanism was through the inhibition of the ERK pathway.


  • Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells

    by Rolis Chien-Wei Hou, Yuh-Shuen Chen, Chia-Hsin Chen, Yi-Hsin Chen, Kee-Ching G. Jeng

    Hydroxyhydroquinone or 1,2,4-benzenetriol (BT) detected in the beverages has a structure that coincides with the water-soluble form of a sesame lignan, sesamol. We previously showed that sesame antioxidants had neuroprotective abilities due to their antioxidant properties and/or inducible nitric oxide synthase (iNOS) inhibition. However, studies show that BT can induce DNA damage through the generation of reactive oxygen species (ROS). Therefore, we were interested to investigate the neuroprotective effect of BT in vitro and in vivo. The results showed that instead of enhancing free radical generation, BT dose-dependently (10–100 μM) attenuated nitrite production, iNOS mRNA and protein expression in lipopolysaccharide (LPS)-stimulated murine BV-2 microglia. BT significantly reduced LPS-induced NF-κB and p38 MAPK activation. It also significantly reduced the generation of ROS in H2O2-induced BV-2 cells and in H2O2-cellfree conditions. The neuroprotective effect of BT was further demonstrated in the focal cerebral ischemia model of Sprague–Dawley rat. Taken together, the inhibition of LPS-induced nitrite production might be due to the suppression of NF-κB, p38 MAPK signal pathway and the ROS scavenging effect. These effects might help to protect neurons from the ischemic injury.


  • Oxidative Toxicity in BV‐2 Microglia Cells: Sesamolin Neuroprotection of H2O2 Injury Involving Activation of p38 Mitogen‐Activated Protein Kinase

    by Rolis Chien‐Wei Hou, Chia‐Chuan Wu, Jing‐Rong Huang, Yuh‐Shuen Chen, Kee‐Ching G. Jeng

    Abstract: Reactive oxygen species (ROS) has been proposed to play a pathogenic role in neuronal injury. Sesame antioxidants that inhibit lipid peroxidation and regulate cytokine production may suppress ROS generation. In this study, we focused on the effect of sesamolin on H2O2‐induced neurotoxicity and ROS production in the murine microglial cell line BV‐2. Results indicate that the H2O2 elicited BV‐2 cell death in a concentration‐ and time‐dependent manner. ROS generation in BV‐2 cells was time‐dependently increased by the H2O2 treatment. Sesamolin reduced ROS generation in BV‐2 cells. p38 mitogen‐activated protein kinase (MAPK) and caspase‐3 were also activated in BV‐2 cells under H2O2 stress. Sesamolin was able to inhibit H2O2‐induced p38 MAPK and caspase‐3 activation and cell death. In addition, sesamolin preserved superoxide dismutase and catalase activities in BV‐2 cells under H2O2 stress. In conclusion, sesamolin protects microglia against H2O2‐induced cell injury and this protective effect was accompanied by its inhibition of p38 MAPK and caspase‐3 activation and ROS production.


  • Protective Effect of α‐Keto‐β‐Methyl‐n‐Valeric Acid on BV‐2 Microglia under Hypoxia or Oxidative Stress

    by Hsueh‐Meei Huang, Hsio‐Chung Ou, Huan‐Lian Chen, Rolis Chien‐Wei Hou, Kee Ching G. Jeng

    Abstract: The α‐ketoglutarate dehydrogenase complex (KGDHC) is a mitochondrial enzyme in the TCA cycle. Inhibition of KGDHC activity by α‐keto‐β‐methyl‐n‐valeric acid (KMV) is associated with neuron death. However, the effect of KMV in microglia is unclear. Therefore, we investigated the effect of KMV on BV‐2 microglial cells exposed to hypoxia or oxidative stress. The results showed that KMV (1‐20 mM) enhanced the cell viability under hypoxia. KMV dose‐dependently reduced ROS and LDH releases from hypoxic BV‐2 cells. KMV also reduced ROS production and enhanced the cell viability under H2O2 but failed to reduce the SIN‐1 and sodium nitroprusside (SNP) toxicity. KMV also reduced caspase‐3 and ‐9 activation under stress. These results suggest that KMV protects BV‐2 cells from stress and acts by reducing ROS production through inhibition of KDGHC.


  • Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation

    by Chiung-Chyi Shen, Hsueh-Meei Huang, Hsiu-Chung Ou, Huan-Lian Chen, Wen-Chi Chen, Kee-Ching Jeng

    Nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in rats; however, its mechanism of action has not been reported. After cerebral ischemia and/or reperfusion, reactive oxygen species (ROS) and reactive nitrogen species may be generated by inflammatory cells through several cellular pathways, which can lead to intracellular calcium influx and cell damage. Therefore, we investigated the mechanisms of action of nicotinamide in neuroprotection under conditions of hypoxia/reoxygenation. Results showed that nicotinamide significantly protected rat primary cortical cells from hypoxia by reducing lactate dehydrogenase release with 1 h of oxygen-glucose deprivation (OGD) stress. ROS production and calcium influx in neuronal cells during OGD were dose-dependently diminished by up to 10 mM nicotinamide (p3 reduced cell injury, caspase-3 cleavage and nuclear condensation (DAPI staining) in neuronal cells under H/R. In addition, nicotinamide diminished c-fos andzif268 immediate-early gene expressions following OGD. Taken together, these results indicate that the neuroprotective effect of nicotinamide might occur through these mechanisms in this in vitro ischemia/reperfusion model.


  • Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells

    by Rolis Chien-Wei Hou, Huan-Lian Chen, Jason T. C. Tzen, Kee-Ching G. Jeng

    Sesame antioxidants have been shown to inhibit lipid peroxidation and regulate cytokine production. In this study, we focused on the effect of sesamin and sesamolin, on nitric oxide (NO) induction by lipopolysaccharides (LPS) in the murine microglial cell line BV-2 and rat primary microglia. The results showed that sesamin and sesamolin significantly inhibited NO production, iNOS mRNA and protein expression in LPS-stimulated BV-2 cells. Sesamin or sesamolin significantly reduced LPS-activated p38 MAPK of BV-2 cells. Furthermore, SB203580, a specific inhibitor of p38 MAP kinase, dose-dependently inhibited NO production in LPS-stimulated BV-2 cells. Taken together, the inhibition of NO production might be due to the reduction of LPS-induced p38 MAPK signal pathway by sesamin and sesamolin.


  • Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells

    by Rolis Chien‐Wei Hou, Hsueh‐Meei Huang, Jason T.C. Tzen, Kee‐Ching G. Jeng

    Reactive oxygen species (ROS) are important mediators of a variety of pathological processes, including inflammation and ischemic injury. The neuroprotective effects of sesame antioxidants, sesamin and sesamolin, against hypoxia or H2O2‐induced cell injury were evaluated by cell viability or lactate dehydrogenase (LDH) activity. Sesamin and sesamolin reduced LDH release of PC12 cells under hypoxia or H2O2‐stress in a dose‐dependent manner. Dichlorofluorescein (DCF)‐sensitive ROS production was induced in PC12 cells by hypoxia or H2O2‐stress but was diminished in the presence of sesamin and sesamolin. We evaluated further the role of mitogen‐activated protein kinases (MAPKs) and caspase‐3 in hypoxia‐induced PC12 cell death. Extracellular signal‐regulated protein kinase (ERK) 1, c‐jun N‐terminal kinase (JNK), and p38 MAPKs of signaling pathways were activated during hypoxia. We found that the inhibition of MAPKs and caspase‐3 by sesamin and sesamolin correlated well with the reduction in LDH release under hypoxia. Furthermore, the hypoxia‐induced apoptotic‐like cell death in cultured cortical cells as detected by a fluorescent DNA binding dye was reduced significantly by sesamin and sesamolin. Taken together, these results suggest that the protective effect of sesamin and sesamolin on hypoxic neuronal and PC12 cells might be related to suppression of ROS generation and MAPK activation.